450 related articles for article (PubMed ID: 25096626)
1. Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer's disease.
Kumar P; Jha NK; Jha SK; Ramani K; Ambasta RK
J Alzheimers Dis; 2015; 43(2):341-61. PubMed ID: 25096626
[TBL] [Abstract][Full Text] [Related]
2. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.
Dickey CA; Kamal A; Lundgren K; Klosak N; Bailey RM; Dunmore J; Ash P; Shoraka S; Zlatkovic J; Eckman CB; Patterson C; Dickson DW; Nahman NS; Hutton M; Burrows F; Petrucelli L
J Clin Invest; 2007 Mar; 117(3):648-58. PubMed ID: 17304350
[TBL] [Abstract][Full Text] [Related]
3. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
[TBL] [Abstract][Full Text] [Related]
4. In vivo evidence of CHIP up-regulation attenuating tau aggregation.
Sahara N; Murayama M; Mizoroki T; Urushitani M; Imai Y; Takahashi R; Murata S; Tanaka K; Takashima A
J Neurochem; 2005 Sep; 94(5):1254-63. PubMed ID: 16111477
[TBL] [Abstract][Full Text] [Related]
5. Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments.
Björkdahl C; Sjögren MJ; Zhou X; Concha H; Avila J; Winblad B; Pei JJ
J Neurosci Res; 2008 May; 86(6):1343-52. PubMed ID: 18061943
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated tau and the neurodegenerative foldopathies.
Kosik KS; Shimura H
Biochim Biophys Acta; 2005 Jan; 1739(2-3):298-310. PubMed ID: 15615647
[TBL] [Abstract][Full Text] [Related]
7. CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.
Shimura H; Schwartz D; Gygi SP; Kosik KS
J Biol Chem; 2004 Feb; 279(6):4869-76. PubMed ID: 14612456
[TBL] [Abstract][Full Text] [Related]
8. Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology.
Zhang S; Zhu Y; Lu J; Liu Z; Lobato AG; Zeng W; Liu J; Qiang J; Zeng S; Zhang Y; Liu C; Liu J; He Z; Zhai RG; Li D
Elife; 2022 Sep; 11():. PubMed ID: 36048712
[TBL] [Abstract][Full Text] [Related]
9. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
10. Hsp multichaperone complex buffers pathologically modified Tau.
Moll A; Ramirez LM; Ninov M; Schwarz J; Urlaub H; Zweckstetter M
Nat Commun; 2022 Jun; 13(1):3668. PubMed ID: 35760815
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of 14-3-3z promotes tau phosphorylation at Ser262 and accelerates proteosomal degradation of synaptophysin in rat primary hippocampal neurons.
Qureshi HY; Han D; MacDonald R; Paudel HK
PLoS One; 2013; 8(12):e84615. PubMed ID: 24367683
[TBL] [Abstract][Full Text] [Related]
12. Involvement of endoplasmic reticulum stress in tauopathy.
Sakagami Y; Kudo T; Tanimukai H; Kanayama D; Omi T; Horiguchi K; Okochi M; Imaizumi K; Takeda M
Biochem Biophys Res Commun; 2013 Jan; 430(2):500-4. PubMed ID: 23237806
[TBL] [Abstract][Full Text] [Related]
13. U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy.
Hatakeyama S; Matsumoto M; Kamura T; Murayama M; Chui DH; Planel E; Takahashi R; Nakayama KI; Takashima A
J Neurochem; 2004 Oct; 91(2):299-307. PubMed ID: 15447663
[TBL] [Abstract][Full Text] [Related]
14. Tau Protein Squired by Molecular Chaperones During Alzheimer's Disease.
Gorantla NV; Chinnathambi S
J Mol Neurosci; 2018 Nov; 66(3):356-368. PubMed ID: 30267382
[TBL] [Abstract][Full Text] [Related]
15. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
Navarrete LP; Pérez P; Morales I; Maccioni RB
Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
[TBL] [Abstract][Full Text] [Related]
16. Tau phosphorylation at Alzheimer's disease-related Ser356 contributes to tau stabilization when PAR-1/MARK activity is elevated.
Ando K; Oka M; Ohtake Y; Hayashishita M; Shimizu S; Hisanaga S; Iijima KM
Biochem Biophys Res Commun; 2016 Sep; 478(2):929-34. PubMed ID: 27520376
[TBL] [Abstract][Full Text] [Related]
17. HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.
Sepulveda-Diaz JE; Alavi Naini SM; Huynh MB; Ouidja MO; Yanicostas C; Chantepie S; Villares J; Lamari F; Jospin E; van Kuppevelt TH; Mensah-Nyagan AG; Raisman-Vozari R; Soussi-Yanicostas N; Papy-Garcia D
Brain; 2015 May; 138(Pt 5):1339-54. PubMed ID: 25842390
[TBL] [Abstract][Full Text] [Related]
18. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
Wang JZ; Grundke-Iqbal I; Iqbal K
Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
[TBL] [Abstract][Full Text] [Related]
19. Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles.
Castillo-Carranza DL; Sengupta U; Guerrero-Muñoz MJ; Lasagna-Reeves CA; Gerson JE; Singh G; Estes DM; Barrett AD; Dineley KT; Jackson GR; Kayed R
J Neurosci; 2014 Mar; 34(12):4260-72. PubMed ID: 24647946
[TBL] [Abstract][Full Text] [Related]
20. Pinning down phosphorylated tau and tauopathies.
Lim J; Lu KP
Biochim Biophys Acta; 2005 Jan; 1739(2-3):311-22. PubMed ID: 15615648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
